-
Signature
-
/s/ Alphonse Valbrune, as Attorney-in-Fact, for Jim Cox
-
Issuer symbol
-
CWAN
-
Transactions as of
-
25 Nov 2025
-
Transactions value $
-
$-1,327,515
-
Form type
-
4
-
Filing time
-
26 Nov 2025, 17:57:31 UTC
Reporting Owners (1)
| Name |
Relationship |
Address |
Signature |
Signature date |
CIK |
| Cox James S |
Chief Financial Officer |
C/O CLEARWATER ANALYTICS HOLDINGS, INC., 777 W. MAIN STREET, SUITE 900, BOISE |
/s/ Alphonse Valbrune, as Attorney-in-Fact, for Jim Cox |
26 Nov 2025 |
0001441361 |
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
CWAN |
Class A Common Stock |
Options Exercise |
$331,879 |
+75,427 |
+22.6% |
$4.40 |
409,410 |
25 Nov 2025 |
Direct |
|
| transaction |
CWAN |
Class A Common Stock |
Tax liability |
$-1,005,994 |
-45,727 |
-11.2% |
$22.00 |
363,683 |
25 Nov 2025 |
Direct |
F1 |
| transaction |
CWAN |
Class A Common Stock |
Sale |
$-653,400 |
-29,700 |
-8.17% |
$22.00 |
333,983 |
25 Nov 2025 |
Direct |
F2 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
CWAN |
Stock Option (Right to Buy) |
Options Exercise |
$0 |
-75,427 |
-29.6% |
$0.000000 |
179,794 |
25 Nov 2025 |
Class A Common Stock |
75,427 |
$4.40 |
Direct |
F3 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: